Konferans Bildirisi
BibTex RIS Kaynak Göster

Batı Nil virüs enfeksiyonu

Yıl 2012, Cilt: 29 Sayı: 3s, 183 - 192, 06.02.2013

Selma Tosun

https://doi.org/10.5835/jecm.omu.29.s3.015

Öz

Batı Nil Virüsü insanlar, atlar, kuşlar ve vahşi hayvanlarda çeşitli nörolojik semptomlara neden olan, artropotlarla bulaştığı için arbovirüs olarak adlandırılan virüs grubunda yer alan, günümüzde yeniden güncellik kazanmış olan sivrisinek kaynaklı bir RNA virüsüdür. Batı Nil Virüsü insan, köpek, at, kuş gibi çeşitli konak türlerinde özellikle santral sinir sistemini enfekte ederek hafif bir klinik tablodan menenjit, ensefalit veya ölüme kadar değişen ciddi nörolojik klinik tablolara yol açabilen geniş spektrumda bir hastalığa neden olabildiği için dünya çapında öneme sahiptir. Ülkemizde geçmiş yıllarda yapılan serolojk çalışmalarda bu virüsün varlığı insanlarda ve hayvanlarda gösterilmiştir. Ülkemizdeki ilk insan olguları 2010 yılında tanımlanmış olup bu derlemede Batı Nil Virüsü ile ilgili bilgilerin gözden geçirilerek sunulması amaçlanmıştır. 

Anahtar Kelimeler

Batı Nil virüsü Santral sinir sistemi enfeksiyonu Ensefalit Arbovirüsler

Kaynakça

  • Allwinn, R., Doerr, H.W., Emmerich, P., Schmitz, H., Preiser, W., 2002. Cross-reactivity in flavivirus serology: New implications of an old finding? Med. Microbiol. Immunol. 190, 199-202.
  • Anderson, J.F., Rahal, J.J., 2002. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg. Infect. Dis. 8, 107-108.
  • Arı, A., 1972. Türkiye’de Arbovirüslerin faaliyeti ve ekolojisi üzerine incelemeler. Türk Hij. Tecr. Biyol. Derg. 32, 134-143.
  • Arpacı, F., Çetin, T., Kubar, A. Özturk, M, 2009. West Nile Virus infection in a patient with acute graft-versus-host disease. Haematologica. 94, 687-689.
  • Autorino, L.G., Battisti, A., Deubel, V., Ferrari, G., Forletta, R., Giovannini, A., Lelli, R., Murri, S., Scicluna, M.T., 2002. West Nile virus epi- demic in horses, Tuscany Region, Italy. Emerg. Infect. Dis. 8, 1372-1378.
  • Beasley, D.W., 2011. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy. 3, 269-285.
  • Ben-Nathan, D., Gershoni-Yahalom, O., Samina, I., Itzchak Samina, Khinich Y., Nur, I., Orgad Laub, O., Gottreich, A., Simanov, M., Porgador, A., Rager-Zisman, B., Orr, N., 2009. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect. Dis. 17, 9-18.
  • Blair, C.D., Adelman, N.Z., Olson, E.K., Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes. Clin. Micro- biol. Rev. 13, 651-661.
  • Bondre, V.P., Jadi, R.S., Mishra, A.C., Yergolkar, P.N., Arankalle, V.A., 2007. West Nile virus isolates from India: evidence for a distinct ge- netic lineage. J. Gen. Virol. 88, 875-884.
  • Briese, T., Rambaut, A., Pathmajeyen, M., Bishara, J., Weinberger, M., Pitlik, S., Lipkin W.I., 2002. Phylogenetic analysis of a human isolate from the 2000 Israel West Nile virus epidemic. Emerg. Infect. Dis. 8, 528-531.
  • Busch. M.R., Kleinman S.H., Tobler, L.H., Kamel, H.T., Norris P.J., Walsh, I., Matud, J.L., Prince, H.E., Lanciotti, R.S., Wright, D.J., Linnen, J.M., Caglioti, S., 2008. Virüs and antibody dynamics in acute West Nile virüs infection. J. Infect. Dis. 198, 984-993.
  • Chan-Tack, K.M., Forrest, G., 2005. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid pa- ralysis. Scand. J. Infect. Dis. 37, 944-946.
  • CDC, 1999. Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis-1999, MMWR Morb Mortal Wkly Rep. 48, 845–849.
  • CDC, 2000. Centers for Disease Control and Prevention. Guidelines for surveillance, prevention, and control of West Nile Virus infection United States. MMWR Morb Mortal Wkly Rep. 49, 25-28.
  • CDC, 2001. Centers for Disease Control and Prevention. Epidemic/Epizootic West Nile Virus in the United States: Guidelines for Surveillance,Prevention, and Control. Available at: http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnv-guidelines-apr-2001.pdf
  • CDC, 2008. Centers for Disease Control and Prevention. Detection of West Nile virus in blood donations-Puerto Rico, 2007. MMWR. 57, 577- 580.
  • Debiasi, R.L., 2011. West Nile virus nueroinvasive disease. Curr. Infect. Dis. Rep. (Epub ahead of print).
  • ECDC, 2011. European Centre for Disease Prevention and Control. Expert consultation on West Nile virus infection. Thessaloniki, ECDC; 25- 26 January 2011. Available at: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=691.
  • Epstein, J.S., 2005. Insights on donor screening for West Nile virus, Transfusion. 45, 460-462.
  • Erdem, H., Pahsa, A., 2003. Yeni bir pandemi mi ? Batı Nil virüs enfeksiyonu. İnfeksiyon Dergisi. 17, 245-249.
  • Ergunay, K., Ozer, N., Us, D., Ozkul, A., Simsek, F., Kaynas, S., Ustacelebi, S., 2007. Seroprevalence of West Nile virus and tick-borne en- cephalitis virus in southeastern Turkey: First evidence for tick-borne encephalitis virus infections. Vector -Borne Zoonot. 7, 157-161.
  • Ergunay, K., Saygan, M.B, Aydoğan, S., Turan, H.M., Özkul, A., Us, D., 2010. West Nile virus seroprevalence in blood donors from Central Anatolia, Turkey. Vector- Borne Zoonot. 10, 771-775.
  • Ergünay, K., 2010. Batı Nil virüsü: Viroloji, epidemiyoloji ve mikrobiyolojik tanı. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 142-160.
  • Ergünay, K., Aydoğan, S, Menemenlioğlu, D., 2010. Ankara Bölgesinde Nedeni Bilinmeyen Merkezi Sinir Sistemi Enfeksiyonlarında Batı Nil Virüsünün Araştırılması. Mikrobiyol. Bul. 44, 255-262.
  • Ertürk, A., 2010. Batı Nil virüsü enfeksiyonunda korunma ve kontrol. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 166- 173.
  • Hayes, E.B., Sejvar, J.J., Zaki, S.R., Lanciotti, R.S., Bode, A.V., Campbell, G.L., 2005. Lanciotti RS, Bode AV, Campbell GL. Virology, pathol- ogy and clinical manifestations of West Nile virus disease. Emerg. Infect. Dis. 11, 1174-1179.
  • Heperkan, Y., Arı, A., 1964. Türkiye’de ARBOR virusları üzerinde bir çalışma. Türk Hij. Tec. Biyol. Derg. 24, 113-117.
  • Hızel, K.,Yenicesu, İ,, Erdal, B., Yeşilyurt, E., Fidan, I., Kalkancı, A., Dilsiz, G., 2010. Investigation of West Nile virus seroprevalence in healthy blood donors. Mikrobiyol. Bul. 44, 425-430.
  • Huhn, G.D., Sejvar, J.J., Montgomery, S.P., Dworkin, S.M., 2003. West Nile virus in the United States: An update on an emerging infectious disease. Am. Fam. Physician. 68, 653-660.
  • Grinev, A., Daniel, S., Stramer, S., Rossmann, S., Caglioti, S., Rios, M., 2008. Rios M. Genetic variability of West Nile virus in US blood do- nors, 2002-2005. Emerg. Infect. Dis. 14, 436-444.
  • Gyure, K.A., 2009. West Nile virus infections. J. Neuropath. Exp. Neur. 68, 1053-1060.
  • Jordan, I., Briese, T., Fischer, N., Lau, J.Y., Lipkin, W.I., 2000. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J. Infect. Dis. 182, 1214-1217.
  • Kalaycıoğlu, H., 2010. Türkiye’de görülen West Nile vakalarının epidemiyolojisi. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 174-183.
  • Kalaycioglu, H., Korukluoglu, G,. Ozkul, A,. Oncul, O., Tosun, S., Karabay, O., Gozalan, A., Uyar, Y., Caglayık, D.Y., Atasoylu, G., Altas, A.B., Yolbakan, S., Ozden, T.N., Bayrakdar, F., Sezak, N., Pelıtlı, T.S., Kurtcebe, Z.O., Aydın, E., Ertek, M., 2012. Emergence of West Nile virüs infection in humnas in Turkey, 2010 to 2011. Eurosurveillance. 17, pp. 20182.
  • Kapoor, H., Signs, K., Somsel, P., Downes, F.P., Clark, P.A., Massey, J.P., 2004. Persistance of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J. Clin. Virol. 31, 289-291.
  • Khabbaz, R.F., Ostroff, S.M., Leduc, J.W., Moseley, R., Hughes, J.M., 2010. Emerging and reemerging infectious disease threats. In: Mandell, G.L, Bennett, J.E. Dolin, R. (eds.) Principles and practice of infectious diseases.7th ed. Philadelphia: Churchill Livingstone Elsevier. pp. 199-219.
  • Kılıç, A., Doğancı, L., 2003. Batı Nil Virus. Türk Mikrobiyol Cem Derg. 33, 284-290.
  • Kramer, L.D., Li, J., Shi, P.Y., 2007. West Nile Virus. Lancet Neurol. 6, 171-181.
  • Leyssen, P., De Clercq, E., Neyts, J., 2000. Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13, 67-82.
  • Lieberman, M.M., Clements, D.E., Ogata, S., Wang, G., Corpuz, G., Wong, T., Martyak, T., Gilson, L., Coller, B-A., Leung, J., Watts, D.M., Tesh, R.B., Siirin, M., da Rosa, A.T., Humphreys, T., Weeks-Levy, C., 2007. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine. 25, 414-423.
  • Lieberman, M.M., Nerurkar, V.R., Luo, H., Cropp, B., Carrion, Jr. R., de la Garza, M., Coller, B-A.,Clements, D., Ogata, S., Wong, T., Martyak, T., Weeks-Levy C., 2009. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin. Vaccine Immunol. 16, 1332-1337.
  • Loginova, SIa, Borisevich, S.V., Pashchenko, I.A, Bondarev, V.P., 2009. Ribavirin prophylaxis and therapy of experimental West Nile fever. Antibiot. Khimioter. 54,17-20.
  • Loroño-Pino, M.A., Blitvich, B.J., Farfán-Ale, J.A., Puerto, F.I., Blanco, J.M., Marlenee, N.L., Rosado-Paredes, E.P., García-Rejón, J.E., Gubler, D.J., Calisher, C.H., Beaty, B.J., 2003. Serologic Evidence of West nile virus ınfection in horses,Yucatan State, Mexico. Emerg. Infect. Dis. 9, 857-859.
  • Marfin, A.A., Gubler, D.J., 2001. West Nile encephalitis: An emerging disease in the United States. Clin. Infect. Dis. 33, 1713-1719.
  • Mather, T, Takeda, T., Tassello, J., Ohagen, A., Serebryanik, D., Kramer, E., Brown, F., Tesh, R., Alford, B., Chapman, J., Lazo, A., 2003. West Nile virus in blood: Stability, distribution, and susceptibility to PEN 110 inactivation. Transfusion. 43, 1029-1037.
  • Meço, O., 1977. Güneydoğu Anadolu halkında Batı Nil ateşi hemaglütinasyon önlenim antikorlarının araştırılması. Mikrobiyol. Bul. 11 3-17.
  • Monini, M., Falcone, E., Busani, L., Romi, R., Ruggeri, F.M., 2010. West Nile virus : Characteristics of an African virus adapting to the third millennium world. Open Virol. J. 22, 42-51.
  • Murgue, B., Murri, S., Zientara, S., Durand, B., Durand, J.P., Zeller, H., 2001. West Nile outbreak in horses in southern France, 2000: The return arter 35 years. Emerg Infect Dis. 7, 692-696.
  • Murray, K.O., Mertens, E., Despres, P., 2010. West Nile virus and its emergence in the United States of America. Vet. Res. 41, 67.
  • Murray, K.O., Walker, C., Gould, E., 2011. The virology, epidemiology, and clinical impact of West Nile virus: A decade of advancements in resarch since its introduction into Western Hemisphere. Epidemiol. Infect. 139, 807-817.
  • Nash, D, Mostashari, F, Fine A, Miller, J., O'Leary, D., Murray, K., Huang, A., Rosenberg, A., Greenberg, A., Sherman, M., Wong, S., Layton, M., 1999. West Nile Outbreak Response Working Group., 2001. The outbreak of West Nile virus infection in the New York City area in 1999. New Engl. J. Med. 344, 1807-1814.
  • Niedrig, M., Sonnenberg, K., Steinhagen, K., Pavveska, J.T., 2007. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. J. Virol. Methods. 139, 103-105.
  • Nosal, B., Pellizzari, R., 2003. West Nile Virus. CMAJ. 168, 1443-1444.
  • Özkul, A., Yıldırım, Y., Pınar, D., Akçalı, A., Yılmaz, V., Çolak, D., 2006. Serological evidence of West Nile virus (WNV) in mammalian spe- cies in Turkey. Epidemiol. Infect. 134, 826-829.
  • Petersen, L.R., Roehring, J.T., 2001. West Nile Virus: A reemerging global pathogen. Emerg. Infect. Dis. 7, 611-614.
  • Radda, A., 1971. Antibodies against group A and group B arboviruses in domestic animals from Turkey. Ege Üni. Tıp Fak. Mec. 10, 227.
  • Reisen, W., Brault, A.C., 2007. West Nile virus in North America: Perspectives on epidemiology and intervention, Pest Manag. Sci. 63, 641- 646.
  • Rossi, S., Ross, T.M., Evans, J.D., 2010. West Nile virus. Clin. Lab. Med. 30, 47-65.
  • Sampathkumar, P., 2003. West Nile Virus: Epidemiology, clinical presentation, diagnosis and prevention. Mayo Clin. Proc. 78, 1137-1144.
  • Serter, F., 1966. Artropodlarla bulaşan virus hastalıklarının (Arbovirus enfeksiyonları) memeleketimizdeki durumu. XII. Türk Mikrobiyoloji Kongre raporu, 104.
  • Serter, D., 1980. Present status of arbovirus seroepidemiology in the Agean region of Turkey. In: Vesenjak-Hirjan J, Caliserh C(eds), Arbovi- ruses in the Mediterranean Countries. Suppl 9, 1980, Stutgart Gustav Fisher Verlas, Germany. pp. 155-161.
  • Serter, D., 2006. Arbovirüs Enfeksiyonları. Turkiye Klinikleri J. Int. Med. Sci. 2, 25-41.
  • Serter, D., 2007. Arbovirüs enfeksiyonlarında tanı ilkeleri. In: Yapar, N., Yıldırmak, T., eds. XIII. Türk Klinik Mikrobiyoloji ve İnfeksiyon
  • Hastalıkları Kongresi. Kongre Kitabı. pp. 106-108.
  • Tardei, G, Ruta, S, Chitu, V, Rossi, C., Tsai, T.F., Cernescu, C., 2000. Evaluation of immunoglobulin M (IgM)and IgG enzyme immunoassays in serological diagnosis of West Nile infection. J. Clin. Microbiol. 38, 2232-2239.
  • Tosun, S., 2010. Batı Nil virüsü enfeksiyonunda klinik ve tedavi. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 161-165.
  • Tosun, S., 2011. Sorun enfeksiyonlarda yaklaşım ve tedavi. Batı Nil Virüsü. 3. Türkiye EKMUD Bilimsel Platformu. 1-5 Mart 2011, İstanbul, 203-212.
  • Ulbert, S., 2011. West Nile virus: The complex biology of an emerging pathogen. Intervirology. 54, 171-184.
  • Wong, S.J., Demarest, V.L., Boyle, R.H., Wang, T., Ledizet, M., Kar, K., Kramer, L.D., Fikrig, E., Raymond A. Koski, A.R., 2004. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J. Clin. Microbiol. 42, 65-72.
  • Yazıcı, Z., 2005. Batı Nil Virus infeksiyonu. İnfeksiyon Dergisi (Turkish Journal of Infection). 19, 139-143.
  • Zeller, H.G., Schuffenecker, I., 2004. West Nile virus: An overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur. J. Clin. Microbiol. 23, 147-156.
  • Zhang, W., Wu, J., Li, Y., Li, F., Njoo, H., 2009. Rapid and accurate in vitro assays for detection of West Nile virus in blood and tissues. Trans- fus. Med. Rev. 23, 146-154.

Yıl 2012, Cilt: 29 Sayı: 3s, 183 - 192, 06.02.2013

Selma Tosun

https://doi.org/10.5835/jecm.omu.29.s3.015

Öz

Kaynakça

  • Allwinn, R., Doerr, H.W., Emmerich, P., Schmitz, H., Preiser, W., 2002. Cross-reactivity in flavivirus serology: New implications of an old finding? Med. Microbiol. Immunol. 190, 199-202.
  • Anderson, J.F., Rahal, J.J., 2002. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg. Infect. Dis. 8, 107-108.
  • Arı, A., 1972. Türkiye’de Arbovirüslerin faaliyeti ve ekolojisi üzerine incelemeler. Türk Hij. Tecr. Biyol. Derg. 32, 134-143.
  • Arpacı, F., Çetin, T., Kubar, A. Özturk, M, 2009. West Nile Virus infection in a patient with acute graft-versus-host disease. Haematologica. 94, 687-689.
  • Autorino, L.G., Battisti, A., Deubel, V., Ferrari, G., Forletta, R., Giovannini, A., Lelli, R., Murri, S., Scicluna, M.T., 2002. West Nile virus epi- demic in horses, Tuscany Region, Italy. Emerg. Infect. Dis. 8, 1372-1378.
  • Beasley, D.W., 2011. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy. 3, 269-285.
  • Ben-Nathan, D., Gershoni-Yahalom, O., Samina, I., Itzchak Samina, Khinich Y., Nur, I., Orgad Laub, O., Gottreich, A., Simanov, M., Porgador, A., Rager-Zisman, B., Orr, N., 2009. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect. Dis. 17, 9-18.
  • Blair, C.D., Adelman, N.Z., Olson, E.K., Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes. Clin. Micro- biol. Rev. 13, 651-661.
  • Bondre, V.P., Jadi, R.S., Mishra, A.C., Yergolkar, P.N., Arankalle, V.A., 2007. West Nile virus isolates from India: evidence for a distinct ge- netic lineage. J. Gen. Virol. 88, 875-884.
  • Briese, T., Rambaut, A., Pathmajeyen, M., Bishara, J., Weinberger, M., Pitlik, S., Lipkin W.I., 2002. Phylogenetic analysis of a human isolate from the 2000 Israel West Nile virus epidemic. Emerg. Infect. Dis. 8, 528-531.
  • Busch. M.R., Kleinman S.H., Tobler, L.H., Kamel, H.T., Norris P.J., Walsh, I., Matud, J.L., Prince, H.E., Lanciotti, R.S., Wright, D.J., Linnen, J.M., Caglioti, S., 2008. Virüs and antibody dynamics in acute West Nile virüs infection. J. Infect. Dis. 198, 984-993.
  • Chan-Tack, K.M., Forrest, G., 2005. Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid pa- ralysis. Scand. J. Infect. Dis. 37, 944-946.
  • CDC, 1999. Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis-1999, MMWR Morb Mortal Wkly Rep. 48, 845–849.
  • CDC, 2000. Centers for Disease Control and Prevention. Guidelines for surveillance, prevention, and control of West Nile Virus infection United States. MMWR Morb Mortal Wkly Rep. 49, 25-28.
  • CDC, 2001. Centers for Disease Control and Prevention. Epidemic/Epizootic West Nile Virus in the United States: Guidelines for Surveillance,Prevention, and Control. Available at: http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnv-guidelines-apr-2001.pdf
  • CDC, 2008. Centers for Disease Control and Prevention. Detection of West Nile virus in blood donations-Puerto Rico, 2007. MMWR. 57, 577- 580.
  • Debiasi, R.L., 2011. West Nile virus nueroinvasive disease. Curr. Infect. Dis. Rep. (Epub ahead of print).
  • ECDC, 2011. European Centre for Disease Prevention and Control. Expert consultation on West Nile virus infection. Thessaloniki, ECDC; 25- 26 January 2011. Available at: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=691.
  • Epstein, J.S., 2005. Insights on donor screening for West Nile virus, Transfusion. 45, 460-462.
  • Erdem, H., Pahsa, A., 2003. Yeni bir pandemi mi ? Batı Nil virüs enfeksiyonu. İnfeksiyon Dergisi. 17, 245-249.
  • Ergunay, K., Ozer, N., Us, D., Ozkul, A., Simsek, F., Kaynas, S., Ustacelebi, S., 2007. Seroprevalence of West Nile virus and tick-borne en- cephalitis virus in southeastern Turkey: First evidence for tick-borne encephalitis virus infections. Vector -Borne Zoonot. 7, 157-161.
  • Ergunay, K., Saygan, M.B, Aydoğan, S., Turan, H.M., Özkul, A., Us, D., 2010. West Nile virus seroprevalence in blood donors from Central Anatolia, Turkey. Vector- Borne Zoonot. 10, 771-775.
  • Ergünay, K., 2010. Batı Nil virüsü: Viroloji, epidemiyoloji ve mikrobiyolojik tanı. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 142-160.
  • Ergünay, K., Aydoğan, S, Menemenlioğlu, D., 2010. Ankara Bölgesinde Nedeni Bilinmeyen Merkezi Sinir Sistemi Enfeksiyonlarında Batı Nil Virüsünün Araştırılması. Mikrobiyol. Bul. 44, 255-262.
  • Ertürk, A., 2010. Batı Nil virüsü enfeksiyonunda korunma ve kontrol. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 166- 173.
  • Hayes, E.B., Sejvar, J.J., Zaki, S.R., Lanciotti, R.S., Bode, A.V., Campbell, G.L., 2005. Lanciotti RS, Bode AV, Campbell GL. Virology, pathol- ogy and clinical manifestations of West Nile virus disease. Emerg. Infect. Dis. 11, 1174-1179.
  • Heperkan, Y., Arı, A., 1964. Türkiye’de ARBOR virusları üzerinde bir çalışma. Türk Hij. Tec. Biyol. Derg. 24, 113-117.
  • Hızel, K.,Yenicesu, İ,, Erdal, B., Yeşilyurt, E., Fidan, I., Kalkancı, A., Dilsiz, G., 2010. Investigation of West Nile virus seroprevalence in healthy blood donors. Mikrobiyol. Bul. 44, 425-430.
  • Huhn, G.D., Sejvar, J.J., Montgomery, S.P., Dworkin, S.M., 2003. West Nile virus in the United States: An update on an emerging infectious disease. Am. Fam. Physician. 68, 653-660.
  • Grinev, A., Daniel, S., Stramer, S., Rossmann, S., Caglioti, S., Rios, M., 2008. Rios M. Genetic variability of West Nile virus in US blood do- nors, 2002-2005. Emerg. Infect. Dis. 14, 436-444.
  • Gyure, K.A., 2009. West Nile virus infections. J. Neuropath. Exp. Neur. 68, 1053-1060.
  • Jordan, I., Briese, T., Fischer, N., Lau, J.Y., Lipkin, W.I., 2000. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J. Infect. Dis. 182, 1214-1217.
  • Kalaycıoğlu, H., 2010. Türkiye’de görülen West Nile vakalarının epidemiyolojisi. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 174-183.
  • Kalaycioglu, H., Korukluoglu, G,. Ozkul, A,. Oncul, O., Tosun, S., Karabay, O., Gozalan, A., Uyar, Y., Caglayık, D.Y., Atasoylu, G., Altas, A.B., Yolbakan, S., Ozden, T.N., Bayrakdar, F., Sezak, N., Pelıtlı, T.S., Kurtcebe, Z.O., Aydın, E., Ertek, M., 2012. Emergence of West Nile virüs infection in humnas in Turkey, 2010 to 2011. Eurosurveillance. 17, pp. 20182.
  • Kapoor, H., Signs, K., Somsel, P., Downes, F.P., Clark, P.A., Massey, J.P., 2004. Persistance of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J. Clin. Virol. 31, 289-291.
  • Khabbaz, R.F., Ostroff, S.M., Leduc, J.W., Moseley, R., Hughes, J.M., 2010. Emerging and reemerging infectious disease threats. In: Mandell, G.L, Bennett, J.E. Dolin, R. (eds.) Principles and practice of infectious diseases.7th ed. Philadelphia: Churchill Livingstone Elsevier. pp. 199-219.
  • Kılıç, A., Doğancı, L., 2003. Batı Nil Virus. Türk Mikrobiyol Cem Derg. 33, 284-290.
  • Kramer, L.D., Li, J., Shi, P.Y., 2007. West Nile Virus. Lancet Neurol. 6, 171-181.
  • Leyssen, P., De Clercq, E., Neyts, J., 2000. Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13, 67-82.
  • Lieberman, M.M., Clements, D.E., Ogata, S., Wang, G., Corpuz, G., Wong, T., Martyak, T., Gilson, L., Coller, B-A., Leung, J., Watts, D.M., Tesh, R.B., Siirin, M., da Rosa, A.T., Humphreys, T., Weeks-Levy, C., 2007. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine. 25, 414-423.
  • Lieberman, M.M., Nerurkar, V.R., Luo, H., Cropp, B., Carrion, Jr. R., de la Garza, M., Coller, B-A.,Clements, D., Ogata, S., Wong, T., Martyak, T., Weeks-Levy C., 2009. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin. Vaccine Immunol. 16, 1332-1337.
  • Loginova, SIa, Borisevich, S.V., Pashchenko, I.A, Bondarev, V.P., 2009. Ribavirin prophylaxis and therapy of experimental West Nile fever. Antibiot. Khimioter. 54,17-20.
  • Loroño-Pino, M.A., Blitvich, B.J., Farfán-Ale, J.A., Puerto, F.I., Blanco, J.M., Marlenee, N.L., Rosado-Paredes, E.P., García-Rejón, J.E., Gubler, D.J., Calisher, C.H., Beaty, B.J., 2003. Serologic Evidence of West nile virus ınfection in horses,Yucatan State, Mexico. Emerg. Infect. Dis. 9, 857-859.
  • Marfin, A.A., Gubler, D.J., 2001. West Nile encephalitis: An emerging disease in the United States. Clin. Infect. Dis. 33, 1713-1719.
  • Mather, T, Takeda, T., Tassello, J., Ohagen, A., Serebryanik, D., Kramer, E., Brown, F., Tesh, R., Alford, B., Chapman, J., Lazo, A., 2003. West Nile virus in blood: Stability, distribution, and susceptibility to PEN 110 inactivation. Transfusion. 43, 1029-1037.
  • Meço, O., 1977. Güneydoğu Anadolu halkında Batı Nil ateşi hemaglütinasyon önlenim antikorlarının araştırılması. Mikrobiyol. Bul. 11 3-17.
  • Monini, M., Falcone, E., Busani, L., Romi, R., Ruggeri, F.M., 2010. West Nile virus : Characteristics of an African virus adapting to the third millennium world. Open Virol. J. 22, 42-51.
  • Murgue, B., Murri, S., Zientara, S., Durand, B., Durand, J.P., Zeller, H., 2001. West Nile outbreak in horses in southern France, 2000: The return arter 35 years. Emerg Infect Dis. 7, 692-696.
  • Murray, K.O., Mertens, E., Despres, P., 2010. West Nile virus and its emergence in the United States of America. Vet. Res. 41, 67.
  • Murray, K.O., Walker, C., Gould, E., 2011. The virology, epidemiology, and clinical impact of West Nile virus: A decade of advancements in resarch since its introduction into Western Hemisphere. Epidemiol. Infect. 139, 807-817.
  • Nash, D, Mostashari, F, Fine A, Miller, J., O'Leary, D., Murray, K., Huang, A., Rosenberg, A., Greenberg, A., Sherman, M., Wong, S., Layton, M., 1999. West Nile Outbreak Response Working Group., 2001. The outbreak of West Nile virus infection in the New York City area in 1999. New Engl. J. Med. 344, 1807-1814.
  • Niedrig, M., Sonnenberg, K., Steinhagen, K., Pavveska, J.T., 2007. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. J. Virol. Methods. 139, 103-105.
  • Nosal, B., Pellizzari, R., 2003. West Nile Virus. CMAJ. 168, 1443-1444.
  • Özkul, A., Yıldırım, Y., Pınar, D., Akçalı, A., Yılmaz, V., Çolak, D., 2006. Serological evidence of West Nile virus (WNV) in mammalian spe- cies in Turkey. Epidemiol. Infect. 134, 826-829.
  • Petersen, L.R., Roehring, J.T., 2001. West Nile Virus: A reemerging global pathogen. Emerg. Infect. Dis. 7, 611-614.
  • Radda, A., 1971. Antibodies against group A and group B arboviruses in domestic animals from Turkey. Ege Üni. Tıp Fak. Mec. 10, 227.
  • Reisen, W., Brault, A.C., 2007. West Nile virus in North America: Perspectives on epidemiology and intervention, Pest Manag. Sci. 63, 641- 646.
  • Rossi, S., Ross, T.M., Evans, J.D., 2010. West Nile virus. Clin. Lab. Med. 30, 47-65.
  • Sampathkumar, P., 2003. West Nile Virus: Epidemiology, clinical presentation, diagnosis and prevention. Mayo Clin. Proc. 78, 1137-1144.
  • Serter, F., 1966. Artropodlarla bulaşan virus hastalıklarının (Arbovirus enfeksiyonları) memeleketimizdeki durumu. XII. Türk Mikrobiyoloji Kongre raporu, 104.
  • Serter, D., 1980. Present status of arbovirus seroepidemiology in the Agean region of Turkey. In: Vesenjak-Hirjan J, Caliserh C(eds), Arbovi- ruses in the Mediterranean Countries. Suppl 9, 1980, Stutgart Gustav Fisher Verlas, Germany. pp. 155-161.
  • Serter, D., 2006. Arbovirüs Enfeksiyonları. Turkiye Klinikleri J. Int. Med. Sci. 2, 25-41.
  • Serter, D., 2007. Arbovirüs enfeksiyonlarında tanı ilkeleri. In: Yapar, N., Yıldırmak, T., eds. XIII. Türk Klinik Mikrobiyoloji ve İnfeksiyon
  • Hastalıkları Kongresi. Kongre Kitabı. pp. 106-108.
  • Tardei, G, Ruta, S, Chitu, V, Rossi, C., Tsai, T.F., Cernescu, C., 2000. Evaluation of immunoglobulin M (IgM)and IgG enzyme immunoassays in serological diagnosis of West Nile infection. J. Clin. Microbiol. 38, 2232-2239.
  • Tosun, S., 2010. Batı Nil virüsü enfeksiyonunda klinik ve tedavi. III. Türkiye Zoonotik Hastalıklar Sempozyumu, Ankara, Türkiye, 1-2 Kasım 2010, 161-165.
  • Tosun, S., 2011. Sorun enfeksiyonlarda yaklaşım ve tedavi. Batı Nil Virüsü. 3. Türkiye EKMUD Bilimsel Platformu. 1-5 Mart 2011, İstanbul, 203-212.
  • Ulbert, S., 2011. West Nile virus: The complex biology of an emerging pathogen. Intervirology. 54, 171-184.
  • Wong, S.J., Demarest, V.L., Boyle, R.H., Wang, T., Ledizet, M., Kar, K., Kramer, L.D., Fikrig, E., Raymond A. Koski, A.R., 2004. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J. Clin. Microbiol. 42, 65-72.
  • Yazıcı, Z., 2005. Batı Nil Virus infeksiyonu. İnfeksiyon Dergisi (Turkish Journal of Infection). 19, 139-143.
  • Zeller, H.G., Schuffenecker, I., 2004. West Nile virus: An overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur. J. Clin. Microbiol. 23, 147-156.
  • Zhang, W., Wu, J., Li, Y., Li, F., Njoo, H., 2009. Rapid and accurate in vitro assays for detection of West Nile virus in blood and tissues. Trans- fus. Med. Rev. 23, 146-154.
Toplam 72 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Internal Medical Sciences
Yazarlar

Selma Tosun

Yayımlanma Tarihi 6 Şubat 2013
Gönderilme Tarihi 30 Eylül 2011
Yayımlandığı Sayı Yıl 2012 Cilt: 29 Sayı: 3s

Kaynak Göster

APA Tosun, S. (2013). Batı Nil virüs enfeksiyonu. Journal of Experimental and Clinical Medicine, 29(3s), 183-192. https://doi.org/10.5835/jecm.omu.29.s3.015
AMA Tosun S. Batı Nil virüs enfeksiyonu. J. Exp. Clin. Med. Şubat 2013;29(3s):183-192. doi:10.5835/jecm.omu.29.s3.015
Chicago Tosun, Selma. “Batı Nil virüs Enfeksiyonu”. Journal of Experimental and Clinical Medicine 29, sy. 3s (Şubat 2013): 183-92. https://doi.org/10.5835/jecm.omu.29.s3.015.
EndNote Tosun S (01 Şubat 2013) Batı Nil virüs enfeksiyonu. Journal of Experimental and Clinical Medicine 29 3s 183–192.
IEEE S. Tosun, “Batı Nil virüs enfeksiyonu”, J. Exp. Clin. Med., c. 29, sy. 3s, ss. 183–192, 2013, doi: 10.5835/jecm.omu.29.s3.015.
ISNAD Tosun, Selma. “Batı Nil virüs Enfeksiyonu”. Journal of Experimental and Clinical Medicine 29/3s (Şubat 2013), 183-192. https://doi.org/10.5835/jecm.omu.29.s3.015.
JAMA Tosun S. Batı Nil virüs enfeksiyonu. J. Exp. Clin. Med. 2013;29:183–192.
MLA Tosun, Selma. “Batı Nil virüs Enfeksiyonu”. Journal of Experimental and Clinical Medicine, c. 29, sy. 3s, 2013, ss. 183-92, doi:10.5835/jecm.omu.29.s3.015.
Vancouver Tosun S. Batı Nil virüs enfeksiyonu. J. Exp. Clin. Med. 2013;29(3s):183-92.
 Kapak Resmi İndir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.